Invuity (IVTY) Stock Price, News & Analysis

Company Overview

Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities. It offers various illuminated surgical devices, including Eikon LT illuminated retractor system for breast/oncoplastic/gynecology/EP/plastic/endocrine surgeries; Eiberg illuminated retractor systems for orthopedic surgeries; PhotonBlade, a recision illuminator for breast/plastics/EP/orthopedics surgeries; PhotonSaber Y, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general/gynecology/plastic surgeries; and PhotonSaber F, a handheld illuminator for spine/orthopedic/neurosurgery surgeries. The company also provides Breiten illuminated retractor systems for spine/orthopedic surgeries; Photonguide XT system, a drop-in intracavity illuminator for spine surgeries; Eika illuminated retractor systems for endocrine/spine/orthopedic surgeries; and PhotonVue, a system used in conjunction with IC Indocyanine for identifying and verifying blood flow in tissue, as well as is used in breast/plastic/colorectal surgeries. It sells its devices through direct sales representatives and independent sales agents; and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. The company was formerly known as Spotlight Surgical, Inc. and changed its name to Invuity, Inc. in 2007. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California.

Key Stats

• Today's Range: $7.39 to $7.39
• 50-Day Range: N/A
• 52-Week Range: $2.35 to $9.55
• Volume: N/A
• Average Volume: 324,995 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IVTY Stock Analysis - Frequently Asked Questions

How were Invuity's earnings last quarter?

Invuity, Inc. (NASDAQ:IVTY) released its quarterly earnings results on Thursday, August, 2nd. The medical instruments supplier reported ($0.37) earnings per share for the quarter, beating the consensus estimate of ($0.47) by $0.10. The medical instruments supplier earned $10.50 million during the quarter, compared to the consensus estimate of $10.73 million.

When did Invuity IPO?

Invuity (IVTY) raised $48 million in an initial public offering on the week of June 15th 2015. The company issued 4,000,000 shares at $12.00 per share. Piper Jaffray, Leerink Partners and Stifel served as the underwriters for the IPO and William Blair was co-manager.

What other stocks do shareholders of Invuity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Invuity investors own include Cornerstone Strategic Investment Fund (CLM), Allena Pharmaceuticals (ALNA), Madrigal Pharmaceuticals (MDGL), Mondi (MNDI), Protalix BioTherapeutics (PLX), SELLAS Life Sciences Group (SLS) and Spero Therapeutics (SPRO).

Company Calendar

• Last Earnings: 8/02/2018
• Today: 9/14/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:IVTY
• CIK: 1393020
• Web: www.invuity.com
• Phone: 415-655-2100
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A